Redhill Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REDHILL, and what generic alternatives to REDHILL drugs are available?
REDHILL has three approved drugs.
There are fifteen US patents protecting REDHILL drugs.
There are one hundred and forty-eight patent family members on REDHILL drugs in forty-seven countries and twenty supplementary protection certificates in sixteen countries.
Summary for Redhill
| International Patents: | 148 |
| US Patents: | 15 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Redhill
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Redhill | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 8,617,530 | See Plans and Pricing | See Plans and Pricing | ||||
| Redhill | TALICIA | amoxicillin; omeprazole magnesium; rifabutin | CAPSULE, DELAYED RELEASE;ORAL | 213004-001 | Nov 1, 2019 | RX | Yes | Yes | 11,135,172 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Redhill | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 7,786,133 | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Redhill | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 7,056,500 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Redhill | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 8,067,431 | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for REDHILL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 12.5 mg and 25 mg | ➤ Subscribe | 2018-09-17 |
International Patents for Redhill Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2303255 | See Plans and Pricing |
| New Zealand | 711754 | See Plans and Pricing |
| European Patent Office | 1894560 | See Plans and Pricing |
| Japan | 4991312 | See Plans and Pricing |
| Hungary | E052411 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Redhill Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1694363 | C 2015 022 | Romania | See Plans and Pricing | PRODUCT NAME: NALOXEGOL SI SARURILE SALE ACCEPTABILE FARMACEUTIC, IN SPECIAL SAREA OXALAT A NALOXEGOLULUI; NATIONAL AUTHORISATION NUMBER: EU/1/14/962; DATE OF NATIONAL AUTHORISATION: 20141208; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/14/962; DATE OF FIRST AUTHORISATION IN EEA: 20141208 |
| 1694363 | PA2015019 | Lithuania | See Plans and Pricing | PRODUCT NAME: NALOXEGOLUM; REGISTRATION NO/DATE: EU/1/14/962 20141208 |
| 1694363 | C20150020 00290 | Estonia | See Plans and Pricing | PRODUCT NAME: NALOKSEGOOL;REG NO/DATE: EU/1/14/962 10.12.2014 |
| 1694363 | 592 | Finland | See Plans and Pricing | |
| 1694363 | 234 5008-2015 | Slovakia | See Plans and Pricing | PRODUCT NAME: OXALAT NALOXEGOLU; REGISTRATION NO/DATE: EU/1/14/962 20141210 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
